Evaluation of Bleeding and Thrombocytopenia in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A Systematic Review

Category Systematic review
JournalBlood
Year 2022
This article has no abstract
Epistemonikos ID: 97ea01b4f0c682defcbdc895192685f319a8171b
First added on: Feb 16, 2025